Cairn Biosciences

company

About

Cairn Biosciences is developing next-generation therapeutics that address significant challenges in the treatment of serious diseases.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$150K
Industries
Biotechnology,Health Care,Life Science,Therapeutics
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Cairn Biosciences is developing next-generation therapeutics that address significant challenges in the treatment of serious diseases.

Cairn’s drug discovery engine addresses the profound unmet need for new tools to decipher cellular complexity and enable scalable discovery of groundbreaking therapies. The company's proprietary approach enables us to monitor multiple dynamic facets of previously inaccessible biology in live cells and fast-track the discovery of a pipeline of drugs for a wide range of indications with an initial focus on cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.05M
Cairn Biosciences has raised a total of $1.05M in funding over 2 rounds. Their latest funding was raised on Aug 9, 2016 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 9, 2016 Grant $0.90M 1 National Science Foundation Detail
Dec 8, 2014 Grant $150K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Cairn Biosciences is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant